Filing Details
- Accession Number:
- 0001209191-18-046392
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-13 16:04:32
- Reporting Period:
- 2018-08-13
- Accepted Time:
- 2018-08-13 16:04:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566373 | Spring Bank Pharmaceuticals Inc. | SBPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339402 | J Martin Driscoll | C/O Spring Bank Pharmaceuticals, Inc. 35 Parkwood Drive Hopkinton MA 01748 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-13 | 4,000 | $12.02 | 60,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
